UNSPSC 51281508: Morinamide or morphazinamide or morinamid

This classification denotes an antitubercular agent with the molecular formula C10H14N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8CFL28PA3W, chemically known as pyrazinecarboxamide, n-(morpholinomethyl)- but generally known as morinamide, which bears US NIH Compound Identifier 70374. European Medicines Agency schedules Morinamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09067MIG. The term MORINAMIDE is an International Non-Proprietary Name.

World Health Organization schedules morinamide in its Anatomical Therapeutic Chemical (ATC) Classification. MORINAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: C1COCCN1CNC(=O)C2=NC=CN=C2.

UNSPSC 51281508 Morinamide or morphazinamide or morinamid is a Commodity code that shows limited alignment with recent state and local procurement activity. The code nominally designates a specific pharmaceutical compound, but the recent solicitations tagged under it encompass a substantially broader scope—naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first aid supplies, and generic multi-source pharmaceuticals and over-the-counter products. State and local governments are procuring these products through competitive bidding (IFB and sealed-bid processes), RFP vehicles for pharmaceutical supply agreements, and RFI mechanisms to gather market intelligence on prescription fulfillment models. The issuing bodies include county health departments (Seminole County, Florida), city fire and rescue divisions (Tampa Fire Department), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across member jurisdictions including Oregon).

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS (due July 26, 2023, per the source record) for 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford. The City of Tampa Purchasing Department solicited sealed bids (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a 5 percent small local business enterprise (SLBE) bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities. The Texas HHS Commission released RFI HHS0017013 (due April 3, 2026) to gather vendor capabilities regarding direct-to-manufacturer prescription programs. The code itself shows little recent activity genuinely tied to morinamide or morphazinamide procurement; the mismatch between the code's nominal pharmaceutical scope and the actual solicitations suggests potential miscoding or a low-activity category in state and local procurement systems.